Mayo Clinic

Phenomix Sciences Launches Three-in-One Obesity Phenotyping Test, Adding Emotional Hunger and Personalized Lifestyle Guidance

Retrieved on: 
Thursday, April 4, 2024
Depression, Gene, Human, Obesity, Learning, Intelligence, Naltrexone/bupropion, Patient, Mayo Clinic, Research, Anxiety, Medicine, Diet, Body mass index, Phenotype, Machine learning

MENLO PARK, Calif., April 4, 2024 /PRNewswire/ -- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of a new MyPhenomeTM test that now allows patients to test for all three identified phenotypes - Emotional Hunger, Hungry Gut and Hungry Brain - in one simple test. For the first time, the new test gives deeper insights into the presence of one or more phenotypes, how that influences an individual's obesity, and an in-depth MyPhenome test report personalized to the patient.

Key Points: 
  • Obesity phenotypes are the combination of genes and other biometric data that cause obesity, first discovered by Phenomix's co-founders and Mayo Clinic physicians, Andres Acosta, M.D.
  • Phenomix co-founders previously identified that patients can exhibit multiple phenotypes , with a primary (leading) phenotype and one or more underlying phenotypes.
  • The new MyPhenome test and report will outline a patients' identified phenotype(s) and personalized context behind the cause of their obesity.
  • Backed by powerful machine learning and groundbreaking research, this is just the beginning of unlocking the potential of obesity precision medicine."

AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress

Retrieved on: 
Tuesday, April 2, 2024
D.C, Public, Mayo Clinic

IRVINE, Calif., April 2, 2024 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans S. Keirstead, Ph.D. will participate in a keynote panel at the World Vaccine Congress taking place April 1-4 in Washington, D.C. Dr. Keirstead will be joined by leading experts in AI and healthcare for a discussion of how public health will be impacted by advancements in AI.

Key Points: 
  • IRVINE, Calif., April 2, 2024 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans S. Keirstead, Ph.D. will participate in a keynote panel at the World Vaccine Congress taking place April 1-4 in Washington, D.C. Dr. Keirstead will be joined by leading experts in AI and healthcare for a discussion of how public health will be impacted by advancements in AI.
  • Details are as follows:
    Gregory Poland, Director of Mayo Vaccine Research Group, Mayo Clinic
    Hans S. Keirstead, Founder & Chief Executive Officer, AIVITA Biomedical, Inc.

Aegis Ventures Announces Partnership with Nine Health Systems to Build and Deploy Healthtech Solutions

Retrieved on: 
Tuesday, April 2, 2024
Stanford University Medical Center, Automation, Ohio State University, Indiana University Health, Health, Partnership, Patient, Mayo Clinic, Record, Consortium, Northwell Health, Novant Health, Ecosystem, Sharp HealthCare, Memorial Hermann Health System, Women's health

NEW YORK, April 2, 2024 /PRNewswire/ -- Today, Aegis Ventures, a New York-based venture studio, welcomed nine leading health systems as founding members of the Digital Consortium. These health systems will innovate directly with Aegis to co-develop, invest in, and deploy healthtech solutions that address healthcare's most pressing quality, equity, and cost problems, and enable them to better care for the communities they serve, while generating diversified sources of revenue.

Key Points: 
  • The health systems collaborating with Aegis include: Endeavor Health, Indiana University Health, Memorial Hermann Health System, Northwell Health, Novant Health, Ochsner Health, The Ohio State University Wexner Medical Center, Sharp HealthCare, and Stanford Health Care.
  • Since its launch in 2020, Aegis Ventures has established a novel approach to how entrepreneurs and health systems collaborate to build and deploy new technologies that improve access, affordability, quality, and sustainability.
  • The Digital Consortium harnesses health systems' collective expertise to foster groundbreaking solutions, redefining healthcare delivery for the better," said Michael Dowling, President and CEO of Northwell Health.
  • "The partnership between Aegis Ventures and Northwell Health epitomizes the transformative impact that new technologies can have on health system patients and employees," said Aegis Ventures Co-Founder and Managing Partner John Beadle.

Tomorrow Health Adds New Executive Growth Leaders to Propel Home-Based Care Delivery

Retrieved on: 
Monday, April 1, 2024
Growth, Epic, Veterans Health Administration, Partnership, Empathy, Health, Patient, Mayo Clinic, Software, Senior, Veteran, Steven Naifeh, Management

NEW YORK, April 1, 2024 /PRNewswire/ --  Tomorrow Health, the leading home-based healthcare platform, today announced the expansion of its growth team with the hiring of Gabriela Perez as Chief Growth Officer, as well as Craig Thompson, General Manager and Senior Vice President of Sales, and Peter Saul, Director of Provider Growth.

Key Points: 
  • Perez brings 20+ years of healthcare and startup leadership experience to Tomorrow Health, where she will lead the growth and scale of Tomorrow Health's home-based care technology to reach more patients across the country.
  • Thompson will lead Tomorrow Health's referring provider and supplier growth teams, taking on ownership of growth and engagement with provider groups, health systems, and suppliers.
  • In his role as Director of Provider Growth at Tomorrow Health, Saul will develop and execute strategic partnerships between Tomorrow Health and referring providers, especially health systems.
  • "The expansion of our growth team comes as we aim to capitalize on significant demand from enterprise partners to enable high-quality home-based care," said Vijay Kedar, founder and CEO of Tomorrow Health.

Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, March 28, 2024
OCT, Growth, International, International Financial Reporting Standards, Mayo Clinic, University, AI, Software, Clinical trial, OTC, S series, Breast cancer, IAS, PINK, Perimeter

TORONTO and DALLAS, March 28, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • TORONTO and DALLAS, March 28, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update.
  • Mr. Mendes continued, "As we enter 2024, patient enrollment is outpacing our original projections for our pivotal clinical trial.
  • In addition, our pipeline of product innovations is growing, with several new product introductions and AI enhancements anticipated this year.
  • The Company will host a conference call and live audio webcast today at 4:30 pm Eastern Time to discuss its fourth quarter and year-end 2023 results and provide a corporate update.

Tired Legs? No Problem for PLAMECA!

Retrieved on: 
Wednesday, March 27, 2024
System, Weight gain, Inflammation, Twitch, Mayo Clinic, Restless legs syndrome, Sleep, Rest, Meal, Quality of life, Itch, Glass, Woman, Restless, Hesperidin, Water, Weather, Dietary supplement

FORT LAUDERDALE, Fla., March 27, 2024 /PRNewswire/ -- Tired legs syndrome is a common issue for many individuals. The restless, twitching symptoms can be distracting and uncomfortable and ultimately impact quality of life. PLAMECA's VENALIGHT PLUS CAPSULES were designed to restore circulation in the legs and eliminate the issue of restless legs.

Key Points: 
  • PLAMECA's VENALIGHT PLUS CAPSULES were designed to restore circulation in the legs and eliminate the issue of restless legs.
  • Also called Restless Legs Syndrome, tired legs is a health condition that occurs when an individual feels a sudden urge to move their legs while in a resting position.
  • "VENALIGHT PLUS is ideal for the treatment and prevention of tired legs," says PLAMECA's managing director, Óscar Fernández.
  • Tired legs are a common issue for many individuals, whether they develop due to warm weather, excessive weight gain, or simply standing for too long.

FormaPath announces the novel tissue biopsy grossing platform: nToto™

Retrieved on: 
Tuesday, March 26, 2024
Mayo Clinic, AP, Clinical professor, USCAP, Comparison, Medical imaging

BALTIMORE, March 26, 2024 /PRNewswire/ -- In conjunction with a poster presentation at the United States and Canada Association of Pathologists Annual (USCAP) meeting titled "Current State of Intra-/Interobserver Accuracy and Reproducibility in Tissue Biopsy Grossing and Comparison to an Automated Vision System" – Poster #198, FormaPath is pleased to announce nToto, a new automated tissue visualization system (ATVS) developed in collaboration with Mayo Clinic's Advanced Diagnostics Laboratory.

Key Points: 
  • FormaPath is pleased to announce nToto, a new automated tissue visualization system
    Common grossing metrics have not been captured or examined before, due to a lack of standardization in tissue grossing techniques.
  • The goal of the study was to characterize and quantify inter- and intra-operator variability in routine gross dissection procedures performed by human technicians.
  • Using the results of this study to establish a baseline for comparison, FormaPath was able to confirm the feasibility of an AI-enabled, automated grossing system for standard tissue biopsies.
  • It is intended to support high-throughput AP Labs seeking to streamline the process of preparing tissue specimens for downstream analysis and reporting.

PathKeeper Surgical enters into know-how agreement with Mayo Clinic for low-radiation pediatric spine surgery

Retrieved on: 
Monday, March 25, 2024
MD, Radiation, Deformity, Machine learning, Mayo Clinic, KFAR, Research, Patient, Surgeon, Standard of care, Scoliosis, Safety, Dentistry

KFAR SABA, Israel, March 25, 2024 /PRNewswire/ -- PathKeeper Surgical, an Israeli medical technology company committed to advancing surgical solutions through innovative camera and machine learning technologies, announced it has entered into a know-how agreement with Mayo Clinic to research radiation levels in pediatric spine surgeries. The research will focus on reducing patient radiation exposure using minimally invasive optical navigation and utilizing intraoperative measurement tools for scoliosis correction, including vertebral body tethering.

Key Points: 
  • PathKeeper Surgical enters a know-how agreement with Mayo Clinic in Rochester, MN.
  • To address the unique challenges of pediatric patients undergoing spine surgery for scoliosis, Mayo Clinic pediatric spine surgeons Noelle Larson, MD, and Todd Milbrandt, MD, are collaborating with PathKeeper Surgical, a company widely known for its cutting-edge optical navigation that prioritize precision, safety, and minimization of radiation exposure.
  • "We are proud to collaborate with Mayo Clinic," said Erez Lampert, founder and Chief Executive Officer at PathKeeper Surgical.
  • The research and development efforts will include refining and expanding the application of PathKeeper's technology to tackle the unique challenges posed by pediatric spine surgery.

Dr. Jason D. Fraser Appointed Division Chief of Pediatric Surgery at Phoenix Children's

Retrieved on: 
Thursday, March 21, 2024
Editorial, Certification, Kansas City University, Mayo Clinic Arizona, Phoenix Children's Hospital, Patient, Mayo Clinic, Trauma, University, MD, American College, General surgery, Hospital, ACS, Mercy, Bariatric surgery, Dentistry

PHOENIX, March 21, 2024 /PRNewswire/ -- Phoenix Children's today announced Jason D. Fraser, MD, will join the rapidly growing health system as division chief of pediatric surgery beginning in April.

Key Points: 
  • PHOENIX, March 21, 2024 /PRNewswire/ -- Phoenix Children's today announced Jason D. Fraser, MD, will join the rapidly growing health system as division chief of pediatric surgery beginning in April.
  • Phoenix Children's is verified by the American College of Surgeons (ACS) as the only Level 1 Children's Surgery Center in Arizona.
  • As division chief of pediatric surgery, Dr. Fraser will provide strategic direction and administrative leadership for neonatal, pediatric and trauma surgery throughout Phoenix Children's health system, which will include three hospital campuses and three ambulatory surgery centers by the end of 2024.
  • Dr. Fraser joins Phoenix Children's from Children's Mercy in Kansas City, Missouri, where he served as medical director of the Opioid Stewardship Program, director of the Pediatric Surgery Fellowship Program, director of Bariatric Surgery and director of General Surgery Residents.

Alo Expands to New Market Opening Avance Care Wilmington, Bringing Comprehensive Primary Care to Southeastern North Carolina

Retrieved on: 
Monday, March 18, 2024
Clinical professor, Mental, Patient, Mayo Clinic, Research, Death, Physical therapy, RSVP, Sports medicine, Triangle, Nursing

Expansion takes Avance Care to first location outside the Triangle and Charlotte areas, as Avance Care opens 36th N.C. office

Key Points: 
  • Expansion takes Avance Care to first location outside the Triangle and Charlotte areas, as Avance Care opens 36th N.C. office
    Patients in fast-growing Wilmington have access to Avance Care's comprehensive, convenient primary care services, including behavioral health and nutrition
    Office located at 3904 Oleander Drive; community invited to open house March 28
    DURHAM, N.C. , March 18, 2024 /PRNewswire/ -- Alo, the North Carolina healthcare company supporting independent providers, is opening its first Avance Care primary care location in Wilmington, bringing a full suite of primary care services to patients in the fast-growing Southeastern North Carolina region.
  • The opening marks the expansion of Avance Care beyond the Triangle and Charlotte and is the 36th location in the state.
  • As more patients seek quality, convenient and affordable care, they're increasingly turning to primary care providers offering multiple services coordinated around their needs.
  • This is especially true in behavioral health, where patients have expressed a desire to have mental health services coordinated by and with their primary care provider.1 Avance Care's integrated model includes collocated access to Avance Care behavioral health, nutrition and other services, coordinated by primary care.